ARTICLE | Company News
Abbott submits DM-1796 NDA
March 31, 2010 1:30 AM UTC
Depomed Inc. (NASDAQ:DEPO) said Abbott Laboratories (NYSE:ABT) submitted an NDA to FDA for DM-1796 to treat post-herpetic neuralgia (PHN). Abbott has North American rights to the once-daily, extended-...